You are here

NANOCOMPOSIX, INC.

Company Information
Address
4878 Ronson Ct Ste K
San Diego, CA 92111-1806
United States


https://www.nanocomposix.com

Information

DUNS: 159070825

# of Employees: 65


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Obscurant Material Drying Processes

    Amount: $111,500.00

    Electromagnetic obscurants and smokes are important components in the defense of DOD weapons, vehicles, and personnel. When deployed, the obscurants decrease the electromagnetic energy available for t ...

    SBIRPhase I2020Department of Defense Army
  2. THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN AND SYNTHESIS A NEW PLGA BASED NANOPARTICLE WITH NANOPARTICLE WITH OPTIMAL PROTEIN-ADJUVANT FORMULATION CO

    Amount: $300,000.00

    Self-amplifying mRNA (saRNA) vaccines offer several advantages. Compared with HIV protein vaccines, they can be rapidly produced with reduced development time and costs by using a common manufacturing ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  3. A point of care test for TB antibiotic concentration in blood

    Amount: $300,000.00

    TuberculosisTBis one of the topcauses of death worldwideTB treatments include combinations of multiple antibiotics and dosage levels over a long period of timeOften the dose must be adjustedLow antibi ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  4. New Carriers Used as Adjuvants for Controlled HIV Immunogen Delivery into Targeted Antigen Presenting Cells

    Amount: $600,000.00

    Despite the global impacts of HIV on human healthwith an estimatedmillion new cases each year andmillion people living with HIVan effective vaccine has not been developedThere are many challenges for ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  5. Rapid diagnostic to determine CMV serological status

    Amount: $1,500,000.00

    The goal of this project is to develop a diagnostic that can support the enrollment of seronegative individuals in clinical trials of candidate cytomegalovirusCMVvaccinesCongenital CMV infection is on ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  6. Ultra-sensitive Rapid Diagnostic Test to Support the End-Game of the Global Program to Eliminate Lymphatic Filariasis

    Amount: $224,246.00

    Project SummaryAbstract Lymphatic filariasisLFcaused by the parasitic filarial worm Wuchereria bancroftiis a disfiguring and debilitating neglected tropical disease that affectsmillion people incountr ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health
  7. Gold nanoparticle laser warming of cryopreserved zebrafish embryos

    Amount: $1,441,693.00

    Project Summary/AbstractLaboratories around the world have produced tens of thousands of distinct zebrafish lines that serve as model organisms for genetic and biomedical research that applies to huma ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  8. The first commercial rapid diagnostic test to detect Paragonimus infections

    Amount: $238,810.00

    Abstract We propose an ultrasensitive rapid diagnostic testRDTto detect exposure to pulmonary flukes of the genus ParagonimusParagonimiasis affects an estimatedmi l l ion people and remains amongst th ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health
  9. Biotemplating for Synthesis of Metal Nanorods Used In Infrared Obscuration

    Amount: $100,000.00

    In this Phase I SBIR, technology to cost-effectively fabricate infrared absorbing nanorods will be developed. Biologically produced high-aspect ratio templates will be surface modified and subsequentl ...

    SBIRPhase I2019Department of Defense Army
  10. Development of a point of care lateral flow diagnostic to test for acute and past hepatitis E (HEV) in saliva

    Amount: $225,000.00

    The goal of this Phase I research project is to develop a point of care lateral flow assay to determine the presence of a serological response to hepatitis E virus in a saliva sampleHepatitis EHEVis a ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government